American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.

Ítems similars

• Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
  per: Gottlieb, K, et al.
  Publicat: (2015)
• Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
  per: D'Haens, G, et al.
  Publicat: (2009)
• The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy.
  per: Travis, S, et al.
  Publicat: (2012)
• The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
  per: D'Haens, G, et al.
  Publicat: (2011)
• Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
  per: Silverberg, MS, et al.
  Publicat: (2005)